HCCS and breast carcinoma: Furthermore, DMFS analysis revealed that patients with low HCCS expression demonstrated significantly higher DMFS compared to those with elevated expression (n = 2765, HR = 1.28 [1.09–1.49], p = 0.002) (Figure 6c), further supporting the prognostic relevance of HCCS in breast cancer progression.